Hab Pharmaceuticals And Research Limited, a active public limited company, was established on 22 January 1997 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U99999MH1997PLC105340. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹20.00 Cr and a paid-up capital of ₹4.15 Cr.
It upholds a compliant status. Employing 197 professional, Its leadership includes Madanan Raghavan Chulliparambil (Director), Renu Sanjiv Garg (Director), Sureshchandra Agrawal (Director). Past directors included Madanan Raghavan Chulliparambil, Renu Sanjiv Garg, Saurabh Krishnakumar Agarwal. It holds ₹29.08 Cr open charges and ₹57.45 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Peninsula Business Park, Tower A, Unit No. 301, 3Rd Floor, Ganpatrao Kadam Marg,Lower Parel, Mumbai, Maharashtra, 400013.
U99999MH1997PLC105340
105340
22 January 1997
₹20.00 Cr
₹4.15 Cr
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Hab Pharmaceuticals And Research Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Madanan Raghavan Chulliparambil | Director | 21 Aug 2021 | Current |
| Renu Sanjiv Garg | Director | 01 Oct 2009 | Current |
| Sureshchandra Agrawal | Director | 04 Oct 2004 | Current |
| Krishnakumar Radharaman Agarwal | Managing Director | 22 Jan 1997 | Current |
| Sanjiv Surajbhan Garg | Whole-Time Director | 22 Jan 1997 | Current |
| Saurabh Krishnakumar Agarwal | Whole-Time Director | 27 Oct 2007 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Nov 2021 | Past |
| Pramod Abcsdd | Additional Director | 27 Sep 2010 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2008 | Past |
| Pramod Abcsdd | Director | 08 Apr 2021 | Past |
| Pramod Abcsdd | Director | 01 Jul 2011 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Hab Pharmaceuticals And Research Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 30.27% increase. The company also saw a substantial improvement in profitability, with a 99.03% increase in profit. The company's net worth Soared by an impressive increase of 60.56%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Hab Pharmaceuticals And Research had a promoter holding of 97.71% and a public holding of 2.29%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹290,815,000.00
₹574,462,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 08 Sep 2023 | Others | ₹29.00 Cr | Open |
| 02 May 2012 | Bank Of Baroda | ₹0.82 M | Open |
| 02 Feb 2023 | Standard Chartered Bank | ₹10.00 Cr | Satisfied |
| 19 Dec 2020 | Yes Bank Limited | ₹9.79 M | Satisfied |
| 14 Sep 2017 | Others | ₹1.43 Cr | Satisfied |
Explore comprehensive loan charge details -
Hab Pharmaceuticals And Research has a workforce of 197 employees as of Mar 10, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Hab Pharmaceuticals And Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hab Pharmaceuticals And Research's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Hab Pharmaceuticals And Research Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
The activity A charge with Others of Rs. 29.00 Cr registered on 08 Sep 2023 with Charge ID 100788786 was modified on 26 Jul 2024. was completed.
Hab Pharmaceuticals And Research Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was recorded as a recent event.
Progress on A charge registered on 19 Dec 2020 via Charge ID 100425114 with Yes Bank Limited was fully satisfied on 22 Mar 2024. was documented.
Progress on A charge registered on 21 Mar 2014 via Charge ID 10515477 with Yes Bank Limited was fully satisfied on 22 Mar 2024. was documented.
The activity A charge registered on 08 Nov 2013 via Charge ID 10463486 with Yes Bank Limited was fully satisfied on 22 Mar 2024. was completed.
The CIN of Hab Pharmaceuticals And Research Limited is U99999MH1997PLC105340.
Hab Pharmaceuticals And Research Limited is headquartered at Peninsula Business Park, Tower A, Unit No. 301, 3Rd Floor, Ganpatrao Kadam Marg,Lower Parel, Mumbai, Maharashtra, 400013.
Hab Pharmaceuticals And Research Limited was incorporated on 22 January 1997.
The current directors of Hab Pharmaceuticals And Research Limited are
The primary industry of Hab Pharmaceuticals And Research Limited is Manufacturing.
Hab Pharmaceuticals And Research Limited is unlisted.
The authorized capital of Hab Pharmaceuticals And Research Limited is ₹20.00 Cr, and the paid-up capital is ₹4.15 Cr.
The compliance status of Hab Pharmaceuticals And Research Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX